Baycol Articles
Bayer
4 September 2006
Bayer updates on Lipobay settlements
31 January 2005
Possible Crestor link with patient death
17 January 2005
Bayer settles 2,861 Lipobay/Baycol cases for $1.1B
27 September 2004
Editor's views on AstaZeneca Exanta woes and Bayer/S-P deal
20 September 2004
Bayer AG to reduce job cuts
19 July 2004
Stock Commentary - Europe
22 March 2004
Bayer has now settled 2,059 Lipobay cases
19 January 2004
Questions being asked on remit of new Italian medicines agency
8 December 2003
Bayer to float chemicals unit; to focus on health care
17 November 2003
Stock Commentary - Europe
29 September 2003
Bayer welcomes latest US Baycol ruling
29 September 2003
Baycol settlements near $500M for Bayer
15 September 2003
Stock Commentary - Europe
18 August 2003
Stock Commentary - Europe
23 June 2003
Downgrade unjust claims Bayer
23 June 2003
Bayer making ground on US Baycol/Lipobay settlements
23 June 2003
Crestor advisory panel raises fears of delay
26 May 2003
Stock Commentary - Europe
26 May 2003
Bayer has now settled 785 Baycol cases
19 May 2003
Bayer forecasts good growth, sales up 4%
5 May 2003
Stock Commentary - Europe
5 May 2003
Stock Commentary - Europe
21 April 2003
Stock Commentary - Europe
14 April 2003
Bayer lifted by second US Baycol trial victory
14 April 2003
Stock Commentary - Europe
31 March 2003
Stock Commentary - Europe
24 March 2003
Bayer's shares rocket on Baycol trial victory
24 March 2003
Stock Commentary - Europe
17 March 2003
Bayer goes on the offensive over Baycol accusations
10 March 2003
Stock Commentary - Europe
10 March 2003
Stock Commentary - Europe
3 March 2003
Bayer's shares in free fall on Baycol tensions
3 March 2003
First launch, in Canada, for AstraZeneca's superstatin Crestor
24 February 2003
Bayer "will not sell pharma business"
24 February 2003
Stock commentary - week to Feb 10 - Europe
17 February 2003
Stock Commentary - Europe
10 February 2003
Bayer to face class action suit over Baycol deaths?
10 February 2003
Stock Commentary - Week to January 27 - Europe
3 February 2003
Bayer now facing 7,400 Baycol law suits
27 January 2003
Merck warns of Zocor, Cordarone interaction
17 June 2002
Bayer boosts first qtr income 18.3%
6 May 2002
Zetia boosts response to statin therapy
25 March 2002
Bayer reflects on "sobering" 2001
18 March 2002
Double-digit turnover growth for Novartis in 2001
11 February 2002
Italy monitoring drugs on the Internet
28 January 2002
Baycol-linked deaths reach 100, says Bayer
28 January 2002
Genaissance completes enrollment in STRENGTH II study.
21 January 2002
Baycol lawsuit against Bayer expanded.
21 January 2002
Latest Baycol suit against Fournier
14 January 2002
Bayer's pharmaceuticals head leaves as partnership rumors arise
14 January 2002
Merck, S-P file in USA for cholesterol drug
7 January 2002
Merck points to robust pipeline despite near-term profits warning
12 December 2001
Stock Commentary - Europe
22 November 2001
Sankyo benefits from Certa withdrawal
22 November 2001
Tokyo pharma stocks - week to November 19
21 November 2001
Bayer reports heavy loss as impact of Baycol withdrawal takes hold
15 November 2001
Bayer pharma sales slump 25%
14 November 2001
BioMerieux-Pierre Fabre licenses pitavastatin
31 October 2001
Tokyo pharma stocks - week to October 29
30 October 2001
Little change in statins Rxing, despite safety concerns
26 October 2001
Merck & Co turnover up 13% but Vioxx sales are slowing down
19 October 2001
Stock Commentary - Europe
18 October 2001
Stock Commentary - Tokyo
18 October 2001
Japan pharma stock market - week to October 15
17 October 2001
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- US Supreme Court says patent settlement can "sometimes" be illegal
